Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
Abstract Background Dalbavancin is a lipoglycopeptide antibiotic approved for treatment of skin and soft tissue infections, administered as a single or two-dose treatment. The extended half-life, good penetration into bone and synovial fluid, and bactericidal activity against gram-positive bacteria,...
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
BMC
2023-10-01
|
| Σειρά: | BMC Infectious Diseases |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12879-023-08709-8 |